COMMUNIQUÉS West-GlobeNewswire

Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
10/09/2026
Results from the planned interim analysis of the Phase 3 REZILIENT3 trial of zipalertinib plus chemotherapy in first-line EGFR exon 20 insertion mutation NSCLC to be presented in Presidential Symposium 2 on Sunday, [...]
LifeLabs Celebrates 11 Family Scholarship Recipients for 2026
10/09/2026
Toronto, Canada, Sept. 10, 2026 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of laboratory diagnostic information and digital health connectivity systems, is proud to announce the outstanding recipients of [...]
Positioning ChemoMetec for future growth
10/09/2026
ANNOUNCEMENT NO. 313 10 September 2026 Annual Report 2025/26 (1 July 2025 - 30 June 2026) Positioning ChemoMetec for future growth Despite changes and uncertainty affecting ChemoMetec's markets, revenue grew by 3% to [...]
Guidance for the 2026/27 financial year
10/09/2026
ANNOUNCEMENT NO. 312 10 September 2026 ChemoMetec today approved the annual report for 2025/26, including the guidance for 2026/27, which is considered inside information. For the financial year 2026/27, ChemoMetec [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
10/09/2026
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026
10/09/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
GENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
Lille (France), Cambridge (Massachusetts, United States), September 10, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver [...]
GENFIT annonce sa participation à la H.C. Wainwright 28th Annual Conference
10/09/2026
Lille (France), Cambridge (Massachusetts, États-Unis), le 10 septembre 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie [...]
Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026
10/09/2026
Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of Schedule II and Schedule IV pain drugs, further differentiating its dual NOP/MOP mechanism from [...]
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
10/09/2026
Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: [...]
Rad Source Technologies Introduces Sterile Insect Farms™
10/09/2026
Now offering Sterile Mosquitoes for Non-Chemical & Non-GMO Vector Control BUFORD, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies, a leading innovator in X-ray solutions for life sciences, is proud [...]
Tecan to participate in upcoming Investor Conference
10/09/2026
Männedorf, Switzerland, September 10, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will participate in the following investor conference next week: 24 th Annual Morgan Stanley Healthcare [...]
IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
10/09/2026
Collaboration with NCI's Cancer Therapy Evaluation Program (CTEP) will evaluate IMNN-001 in new indications and combination regimens IMUNON retains ownership of its background intellectual property with an opportunity [...]
Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment
10/09/2026
Access the segment here ISELIN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab- [...]
Canada Steps Up to Support Global Cancer Care with First Contribution to IAEA’s Rays of Hope Initiative
10/09/2026
TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The Canadian Nuclear Isotope Council (CNIC) today announced Canada’s first official contribution to the International Atomic Energy Agency’s (IAEA) Rays of Hope initiative, a [...]
UPDATE -- Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
10/09/2026
PARAMUS, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, today [...]
Interra Health Adds Support for New GLP-1 Bridge Program, Helping Seniors on Medicare Access Weight-Loss Medications
10/09/2026
Within just two months, the program has reached 30,000+ prescribers and delivered 170,000+ point-of-prescribe alerts, helping Medicare patients access GLP-1 medication for obesity for just $50/month BOSTON, Sept. 10, [...]
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
10/09/2026
SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that [...]
Vanquish Brands Partners with Select BC Craft Growers to Bring Premium Cannabis to Markets Across Canada Via the Pistol and Paris Brand
10/09/2026
AGASSIZ, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Vanquish Holdings Inc. (“Vanquish”), operating under the Vanquish Brands name, is a Canadian cannabis house-built Legacy to Legal™, combining the standards, [...]

Pages